DD219769A5 - Verfahren zur herstellung von 1,3-dioxan-5-yl-alkansaeure-derivaten - Google Patents

Verfahren zur herstellung von 1,3-dioxan-5-yl-alkansaeure-derivaten Download PDF

Info

Publication number
DD219769A5
DD219769A5 DD83264391A DD26439183A DD219769A5 DD 219769 A5 DD219769 A5 DD 219769A5 DD 83264391 A DD83264391 A DD 83264391A DD 26439183 A DD26439183 A DD 26439183A DD 219769 A5 DD219769 A5 DD 219769A5
Authority
DD
German Democratic Republic
Prior art keywords
carbon atoms
formula
hydroxy
compound
alkyl
Prior art date
Application number
DD83264391A
Other languages
German (de)
English (en)
Inventor
Andrew G Brewster
Peter W R Caulkett
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of DD219769A5 publication Critical patent/DD219769A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD83264391A 1982-05-12 1983-05-12 Verfahren zur herstellung von 1,3-dioxan-5-yl-alkansaeure-derivaten DD219769A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8213702 1982-05-12

Publications (1)

Publication Number Publication Date
DD219769A5 true DD219769A5 (de) 1985-03-13

Family

ID=10530304

Family Applications (2)

Application Number Title Priority Date Filing Date
DD83250869A DD212515A5 (de) 1982-05-12 1983-05-12 1,3-dioxan-5-ylalkensaeure-derivate
DD83264391A DD219769A5 (de) 1982-05-12 1983-05-12 Verfahren zur herstellung von 1,3-dioxan-5-yl-alkansaeure-derivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD83250869A DD212515A5 (de) 1982-05-12 1983-05-12 1,3-dioxan-5-ylalkensaeure-derivate

Country Status (32)

Country Link
US (3) US4567197A (es)
EP (1) EP0094239B1 (es)
JP (1) JPS58222081A (es)
KR (1) KR880002001B1 (es)
AR (1) AR240817A1 (es)
AT (1) ATE28329T1 (es)
AU (1) AU562056B2 (es)
CA (4) CA1258464A (es)
CS (2) CS245795B2 (es)
CY (1) CY1453A (es)
DD (2) DD212515A5 (es)
DE (1) DE3372483D1 (es)
DK (1) DK163431C (es)
ES (4) ES8407038A1 (es)
FI (1) FI80027C (es)
GB (1) GB8310407D0 (es)
GR (1) GR78138B (es)
HK (1) HK17889A (es)
HU (1) HU198705B (es)
IE (1) IE55114B1 (es)
IL (1) IL68628A0 (es)
KE (1) KE3823A (es)
MW (1) MW1583A1 (es)
NO (1) NO162383B (es)
NZ (1) NZ204202A (es)
PH (1) PH21691A (es)
PL (3) PL140462B1 (es)
PT (1) PT76684B (es)
SG (1) SG57088G (es)
SU (1) SU1277893A3 (es)
ZA (1) ZA833179B (es)
ZW (1) ZW10083A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
FR2551446B1 (fr) * 1983-08-31 1987-03-20 Elf Aquitaine Compositions de resines ayant une resistance amelioree au choc renfermant un polymere thermoplastique, un additif choc du type copolymere greffe, et eventuellement d'autres additifs, et copolymere greffe correspondant, a caractere d'additif choc
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8330097D0 (en) * 1983-11-11 1983-12-21 Ici Plc Cyclic ethers
GB8330094D0 (en) * 1983-11-11 1983-12-21 Ici Plc Diphenyl compounds
GB8417314D0 (en) * 1984-07-06 1984-08-08 Ici Plc Carboxylic acid derivatives
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
DE3685775T2 (de) * 1985-05-10 1993-01-21 Ici Plc Alkenderivate.
GB8511894D0 (en) * 1985-05-10 1985-06-19 Ici Plc Phenol derivatives
GB8511895D0 (en) * 1985-05-10 1985-06-19 Ici Plc Heterocyclic compounds
HU198706B (en) * 1985-05-10 1989-11-28 Ici Plc Process for producing 1,3-dioxan-ethers and pharmaceutical compositions containing them
GB8511892D0 (en) * 1985-05-10 1985-06-19 Ici Plc Fluoralkane derivatives
GB8511897D0 (en) * 1985-05-10 1985-06-19 Ici Plc Carboxylic acids
GB8511891D0 (en) * 1985-05-10 1985-06-19 Ici Plc Alkenoic acids
ATE56967T1 (de) * 1985-11-12 1990-10-15 Ici Plc Amidderivate.
GB8611174D0 (en) * 1986-05-08 1986-06-18 Ici Plc Amide derivatives
GB8531892D0 (en) * 1985-12-30 1986-02-05 Ici Plc Carboxylic acids
DE3603662A1 (de) * 1986-02-06 1987-08-13 Basf Ag Acetalisierte oder ketalisierte dihydroxyaldehyde, verfahren zu ihrer herstellung und diese enthaltende loesungen
GB8626296D0 (en) * 1986-11-04 1986-12-03 Ici Plc Therapeutic agents
GB8626297D0 (en) * 1986-11-04 1986-12-03 Ici Plc Pharmaceutical compositions
GB8709794D0 (en) * 1987-04-24 1987-05-28 Ici Plc Heterocyclic acids
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
EP0346511A1 (en) * 1988-06-15 1989-12-20 Fujisawa Pharmaceutical Co., Ltd. Oxygen-containing hererocyclic compound, processes for their preparation and pharmaceutical compositions comprising them
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives
CN1034120C (zh) * 1988-10-21 1997-02-26 曾尼卡有限公司 制备二噁烷链烯酸衍生物的方法
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
US5925795A (en) * 1996-09-16 1999-07-20 Zeneca Limited Processes for the preparation of aryl-β-diketones, arylpyrimidine ketones and crop protection intermediates
GB0413970D0 (en) * 2004-06-22 2004-07-28 Syngenta Participations Ag Chemical compounds
CA2637803A1 (en) * 2006-01-18 2007-12-06 Evolva Sa Ppar modulators
EP2124558A4 (en) * 2007-01-18 2010-07-14 Evolva Sa SUBSTITUTED 1, 3-DIOXANES AND THEIR USE
CA2676435C (en) * 2007-01-18 2015-03-24 Evolva Sa Substituted 1,3-dioxanes useful as ppar modulators
CA2871545A1 (en) * 2012-05-18 2013-11-21 Sanofi Benzo[1,3]dioxine derivatives and their use as lpar5 antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243592A (en) * 1979-03-12 1981-01-06 The Upjohn Company 9,11-Dideoxy-10-oxa-TXB compounds
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8417314D0 (en) * 1984-07-06 1984-08-08 Ici Plc Carboxylic acid derivatives

Also Published As

Publication number Publication date
EP0094239B1 (en) 1987-07-15
KR880002001B1 (ko) 1988-10-11
DK163431C (da) 1992-07-20
SU1277893A3 (ru) 1986-12-15
CA1268772A (en) 1990-05-08
PL140274B1 (en) 1987-04-30
CS333683A2 (en) 1985-09-17
EP0094239A3 (en) 1984-12-12
US5166377A (en) 1992-11-24
CS245783B2 (en) 1986-10-16
GR78138B (es) 1984-09-26
GB8310407D0 (en) 1983-05-25
NZ204202A (en) 1986-05-09
DK211883A (da) 1983-11-13
PL250098A1 (en) 1985-07-02
PT76684B (en) 1986-01-14
IL68628A0 (en) 1984-05-31
ES8608507A1 (es) 1986-06-16
FI831664A0 (fi) 1983-05-12
JPH0378389B2 (es) 1991-12-13
KR840004739A (ko) 1984-10-24
HU198705B (en) 1989-11-28
DK163431B (da) 1992-03-02
FI831664L (fi) 1983-11-13
ZA833179B (en) 1984-04-25
ATE28329T1 (de) 1987-08-15
FI80027C (fi) 1990-04-10
DE3372483D1 (de) 1987-08-20
PL140462B1 (en) 1987-04-30
ES522331A0 (es) 1984-08-16
NO162383B (no) 1989-09-11
PT76684A (en) 1983-06-01
CA1258464A (en) 1989-08-15
PL241920A1 (en) 1985-03-26
EP0094239A2 (en) 1983-11-16
MW1583A1 (en) 1985-02-13
CA1268771C (es) 1990-05-08
NO831679L (no) 1983-11-14
CS245795B2 (en) 1986-10-16
ES8700250A1 (es) 1986-10-16
PH21691A (en) 1988-01-13
US4745198A (en) 1988-05-17
DD212515A5 (de) 1984-08-15
IE55114B1 (en) 1990-06-06
HK17889A (en) 1989-03-10
ZW10083A1 (en) 1984-11-28
FI80027B (fi) 1989-12-29
KE3823A (en) 1988-10-21
ES8407038A1 (es) 1984-08-16
SG57088G (en) 1989-01-27
ES528575A0 (es) 1986-10-16
PL140463B1 (en) 1987-04-30
CY1453A (en) 1989-07-21
IE831005L (en) 1983-11-12
ES528577A0 (es) 1986-06-16
AU1422383A (en) 1983-11-17
ES528576A0 (es) 1986-10-16
PL250099A1 (en) 1985-07-02
US4567197A (en) 1986-01-28
ES8700249A1 (es) 1986-10-16
DK211883D0 (da) 1983-05-11
JPS58222081A (ja) 1983-12-23
CA1268771A (en) 1990-05-08
AR240817A2 (es) 1991-02-28
AR240817A1 (es) 1991-02-28
CA1269109A (en) 1990-05-15
AU562056B2 (en) 1987-05-28
CS725784A2 (en) 1985-09-17

Similar Documents

Publication Publication Date Title
DD219769A5 (de) Verfahren zur herstellung von 1,3-dioxan-5-yl-alkansaeure-derivaten
EP0025192B1 (de) Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
CH646426A5 (en) Process for the preparation of hydantoin derivatives
DD209446A5 (de) Verfahren zur herstellung von neuen aromatischen verbindungen
EP0177960A2 (de) Tetrahydronaphtalinderivate, Verfahren und Zwischenprodukte zu deren Herstellung sowie diese enthaltende Arzneimittel
DD272648A5 (de) Chromon-derivate
DE3685775T2 (de) Alkenderivate.
DE60121809T2 (de) Materialien und verfahren zur herstellung von stilbenen
DE69427228T2 (de) Neue 1,3-benzodioxol und 1,2-dialkoxybenzol derivate als augendrucksenkende mittel
EP0093084A1 (de) 1-Carboxyalkanoylindolin-2-carbonsäure-ester, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
DD251749A5 (de) Verfahren zur herstellung von 2,4-diphenyl-1,3-dioxian-derivaten
DE3874394T2 (de) 1,3-dioxane.
DE3782396T2 (de) Pharmazeutische zusammensetzungen, enthaltend ein 2,4-diphenyl-1,3-dioxane derivat und einen inhibitor des thromboxan a2 synthese.
DE69009887T2 (de) Bizyklische Derivate.
CH618165A5 (en) Process for the preparation of novel dibenzofuran derivatives and their salts
DE3125059A1 (de) Dioxybenzoletherderivate, diese enthaltende arzneimittel, verfahren zu ihrer herstellung und ihre verwendung
DD252601A5 (de) Verfahren zur herstellung von dihydropyridinderivaten
DE69003616T2 (de) Diarylcycloalkanether.
EP0542671B1 (de) Substituierte Hydrochinonderivate als Zwischenprodukte von Benzofuranderivaten
CH638795A5 (en) 1-[3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl]-4-arylpiperazine derivatives and process for their preparation
DD251339A5 (de) Verfahren zur herstellung von neuen phenolderivaten
DE2458911A1 (de) 11,12-secoprostaglandine und verfahren zu ihrer herstellung
DE4115465A1 (de) Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b)pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
DD201678A5 (de) Verfahren zur herstellung von 1,5-bis-(1,4-benzodioxin-2-yl)-3-azapentan-1,5-diolen, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung
AT371448B (de) Verfahren zur herstellung von neuen cis-4a-phenyl -isochinolin-derivaten und ihren saeureadditionssalzen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee